Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

[Effect of intensive rosuvastatin therapy on adhesion molecules and the upstream mechanism in patients with peripheral atherosclerosis].

Du R, Ye P, Yan G, Deng Z, Liang W, Zhang H, Geng M, Guo Z, Wu H.

Nan Fang Yi Ke Da Xue Xue Bao. 2012 Nov;32(11):1610-4. Chinese.

2.

Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.

Monetti M, Canavesi M, Camera M, Parente R, Paoletti R, Tremoli E, Corsini A, Bellosta S.

Pharmacol Res. 2007 May;55(5):441-9. Epub 2007 Feb 12.

PMID:
17350858
3.

Laminar shear stress prevents simvastatin-induced adhesion molecule expression in cytokine activated endothelial cells.

Rossi J, Rouleau L, Emmott A, Tardif JC, Leask RL.

Eur J Pharmacol. 2010 Dec 15;649(1-3):268-76. doi: 10.1016/j.ejphar.2010.09.016. Epub 2010 Sep 19.

PMID:
20863785
4.

Prevention of atherosclerosis in patients living with HIV.

De Lorenzo F, Boffito M, Collot-Teixeira S, Gazzard B, McGregor JL, Shotliff K, Xiao H.

Vasc Health Risk Manag. 2009;5(1):287-300. Epub 2009 Apr 8.

5.

Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.

Liu B, Zhang JY, Cao HM, Wang Q, Wang HB.

Intern Med. 2012;51(10):1177-82. Epub 2012 May 15.

6.

Effects of lipid-lowering therapy with rosuvastatin on atherosclerotic burden in patients with chronic kidney disease.

Sawara Y, Takei T, Uchida K, Ogawa T, Yoshida T, Tsuchiya K, Nitta K.

Intern Med. 2008;47(17):1505-10. Epub 2008 Sep 1.

7.

Dealcoholised beers reduce atherosclerosis and expression of adhesion molecules in apoE-deficient mice.

Martinez N, Urpi-Sarda M, Martinez-Gonzalez MA, Andres-Lacueva C, Mitjavila MT.

Br J Nutr. 2011 Mar;105(5):721-30. doi: 10.1017/S0007114510004289. Epub 2010 Dec 7.

8.

Effect of rosuvastatin on OX40L and PPAR-γ expression in human umbilical vein endothelial cells and atherosclerotic cerebral infarction patients.

Zhang JY, Liu B, Wang YN, Zhang WN, Wang FJ.

J Mol Neurosci. 2014 Feb;52(2):261-8. doi: 10.1007/s12031-013-0134-1. Epub 2013 Oct 27.

PMID:
24163149
9.

Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.

Mok CC, Wong CK, To CH, Lai JP, Lam CS.

Arthritis Care Res (Hoboken). 2011 Jun;63(6):875-83. doi: 10.1002/acr.20440.

10.

Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells.

Takahashi M, Ikeda U, Masuyama J, Kitagawa S, Kasahara T, Shimpo M, Kano S, Shimada K.

Cardiovasc Res. 1996 Aug;32(2):422-9.

PMID:
8796130
11.

Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells.

Couffinhal T, Duplàa C, Moreau C, Lamazière JM, Bonnet J.

Circ Res. 1994 Feb;74(2):225-34.

12.

Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.

Lekakis J, Ikonomidis I, Papoutsi Z, Moutsatsou P, Nikolaou M, Parissis J, Kremastinos DT.

Int J Cardiol. 2010 Mar 4;139(2):150-8. doi: 10.1016/j.ijcard.2008.10.010. Epub 2008 Nov 11.

PMID:
19004511
13.

The beneficial effects of rosuvastatin are independent of zinc supplementation in patients with atherosclerosis.

Dias PC, Sena-Evangelista KC, Paiva MS, Ferreira DQ, Ururahy MA, Rezende AA, Abdalla DS, Pedrosa LF.

J Trace Elem Med Biol. 2014 Apr;28(2):194-9. doi: 10.1016/j.jtemb.2014.01.003. Epub 2014 Jan 29.

PMID:
24560278
14.

Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment.

Marino F, Maresca AM, Cosentino M, Castiglioni L, Rasini E, Mongiardi C, Maio RC, Legnaro M, Schembri L, Dentali F, Grandi AM, Guasti L.

Cardiovasc Diabetol. 2012 Dec 22;11:153. doi: 10.1186/1475-2840-11-153.

15.

Anti-atherosclerotic activity of platycodin D derived from roots of Platycodon grandiflorum in human endothelial cells.

Wu J, Yang G, Zhu W, Wen W, Zhang F, Yuan J, An L.

Biol Pharm Bull. 2012;35(8):1216-21.

16.
18.

Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.

Guo H, Shi Y, Liu L, Sun A, Xu F, Chi J.

Arch Med Res. 2009 Jul;40(5):345-51. doi: 10.1016/j.arcmed.2009.07.006.

PMID:
19766896
19.

Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early stages of atherosclerosis in a rat model.

Fotis L, Agrogiannis G, Vlachos IS, Pantopoulou A, Margoni A, Kostaki M, Verikokos C, Tzivras D, Mikhailidis DP, Perrea D.

In Vivo. 2012 Mar-Apr;26(2):243-50.

PMID:
22351665

Supplemental Content

Support Center